Stockreport

How Investors May Respond To Edgewise Therapeutics (EWTX) Long-Term Sevasemten Data at World Muscle Congress [Yahoo! Finance]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF muscular dystrophies, at the 30th Annual Congress of the World Muscle Society in Vienna on October 8, 2025. This update, featuring data from the CANYON and MESA trials [Read more]